Clinical Data Shares Rise 8 Percent in Advance of Stock Split | GenomeWeb
NEW YORK (GenomeWeb News) - Clinical Data's share price climbed 8 percent to $39 a share in late-morning trading today, reaching a new 52-week high.
 
Earlier this month, the company authorized a 3-for-2 stock split for shareholders of record as of Sept. 24. The new shares will be distributed Oct. 1.
 
Clinical Data’s shares are up more than 12 percent for the week beginning Sept. 24.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.